KDDF, J&J Launch Joint Korea Diabetes R&D Program
This article was originally published in PharmAsia News
South Korea is continuing to step up open innovation initiatives with the multinational pharma sector, with the aim of accelerating global licensing out deals by domestic companies. In its latest efforts, the state-run Korea Drug Development Fund (KDDF) has tied up with J&J Innovation to develop and commercialize novel Korea-originated diabetes drugs for the global market.
Register for our free email digests: